Company Number: 12890539

Analysis Date: 2025-07-29 19:33 UTC

Financial Health Assessment of LYTHIUM LTD

---

1. Financial Health Score: D

Explanation:
LYTHIUM LTD exhibits clear symptoms of financial distress, primarily due to significant and persistent negative net assets and shareholders' funds. Despite being current on filings and having director support, the company's balance sheet shows a weak financial position, indicating a fragile health status. The score D reflects a critical but not yet terminal condition, requiring urgent management attention to prevent deterioration.

---

2. Key Vital Signs

Metric	Latest Value (£)	Interpretation
Current Assets	819	Very low short-term liquid resources available.
Current Liabilities	86,840	Substantial short-term obligations, outstripping current assets massively.
Net Current Assets	-86,021	Negative working capital indicates immediate liquidity strain.
Net Assets (Shareholders' Funds)	-86,821	The company’s total liabilities exceed its assets, indicating insolvency on a balance sheet basis.
Share Capital	800	Minimal equity contribution from shareholders.
Average Staff Number	4	Small workforce, consistent with micro-entity status.
Going Concern Statement	Directors rely on ongoing support from themselves and a related company for survival.

Interpretation of Vital Signs:
The "vital signs" of LYTHIUM LTD reveal a company under severe financial strain. Negative net assets and working capital are akin to a patient with dangerously low blood pressure and oxygen levels—critical warning signs. The minimal current assets compared to substantial liabilities suggest a poor liquidity position, threatening the company’s ability to meet short-term debts. The directors’ reliance on external support to continue operations indicates that the company’s financial "immune system" is compromised.

---

3. Diagnosis

Underlying Financial Health:
LYTHIUM LTD is experiencing chronic financial distress with liabilities far exceeding assets and very limited cash or liquid resources. The recurring negative net asset position over multiple years signals ongoing losses or accumulated deficits, akin to a chronic illness that has not been effectively managed. The company is not yet in liquidation or formal insolvency, but the financial statements highlight a fragile state that depends heavily on director and related-party support to remain a going concern.

Symptoms of Distress Observed:

• Persistently negative equity and net current assets
• Severe liquidity shortfall (current liabilities over 100 times current assets)
• Minimal capital buffer and limited operational scale (micro-entity size)
• Dependence on external financial support (directors/related company) for survival

These symptoms suggest that without intervention, the company risks "organ failure" in financial terms—i.e., insolvency or forced liquidation.

---

4. Recommendations

Immediate Actions to Improve Financial Wellness:

• Capital Injection: The company needs an urgent infusion of equity or long-term funding to restore positive net assets and improve liquidity. This can be through shareholder loans, new investment, or asset sales.

• Cost Control & Operational Efficiency: Review and reduce operating costs where possible to conserve cash. Streamlining operations can help improve cash flow and reduce dependency on external support.

• Debt Restructuring: Engage with creditors to renegotiate payment terms, potentially converting some current liabilities into longer-term debts to ease immediate liquidity pressures.

• Business Model Review: Assess the current business model and market positioning to identify opportunities for revenue growth or diversification to improve profitability.

• Governance & Oversight: Strengthen financial controls and reporting to ensure early detection of financial issues and timely decision-making. Directors should monitor cash flow closely and adjust strategy accordingly.

• Going Concern Monitoring: Given the directors’ reliance on external support, formalize agreements and contingency plans to manage risks associated with funding withdrawal.

---

Executive Summary